EMD Serono Launches MS-LINK Research Network to Improve Patient Care
News
EMD Serono, the biopharmaceutical division of Merck KGaA in the U.S. and Canada, announced the launch of the company’s Multiple Sclerosis Leadership and Innovation Network (MS-LINK), an interdisciplinary research ... Read more